By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Johannes Vermeerplain 9-1

Amsterdam      The Netherlands
Phone: 31-20-6645500 Fax: n/a



Company News
New Research Suggests Potential For Additional Clinical Utility Of QIAGEN N.V. (QGEN)'s QuantiFERON-TB Gold Plus 4/13/2017 11:43:42 AM
QIAGEN N.V. (QGEN) To Report First Quarter 2017 Results 4/6/2017 8:56:00 AM
QIAGEN N.V. (QGEN)'s GeneReader NGS System Gains Further Validation In Oncology Research Applications With New Independent Performance Review Data 4/3/2017 9:35:14 AM
QIAGEN N.V. (QGEN) Expands Liquid Biopsy Pipeline With AR-V7 Test In Prostate Cancer 4/3/2017 9:29:19 AM
QIAGEN N.V. (QGEN) Joins CANCER-ID Consortium For Liquid Biopsy Workflows 3/31/2017 9:46:19 AM
QIAGEN N.V. (QGEN) Launches First FDA-Cleared JAK2 Test For Certain Type Of Leukemia 3/30/2017 7:34:17 AM
New Study Published In Lancet Respiratory Medicine Highlights QIAGEN N.V. (QGEN)'s Quantiferon-TB Potential To Predict Active Tuberculosis Risk In Infants 2/16/2017 8:22:59 AM
QIAGEN N.V. (QGEN) Reports Results For Fourth Quarter And Full-Year 2016 2/6/2017 8:53:23 AM
QIAGEN N.V. (QGEN) Hereditary And Rare Disease Solution Chosen By Genomics England 1/31/2017 10:12:58 AM
QIAGEN N.V. (QGEN)'s QuantiFERON-TB Test Wins Tender For Testing Of Republic Of Korea Armed Forces Recruits 1/27/2017 7:47:35 AM